Market Cap

Ardelyx, Inc. Market Capitalization:

$1.49 Billion

USD as of Jan. 1, 2026

business Ardelyx, Inc. Company Profile

Ardelyx, Inc. Main Stock Listing

NASDAQ: ARDX

Market Capitalization History of Ardelyx, Inc.

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Biotechnology
Company Market Cap (USD)
Novo Nordisk $158.96 B
Vertex Pharmaceuticals Incorporated $115.92 B
CSL Limited $95.75 B
Regeneron Pharmaceuticals, Inc. $82.28 B
Marinomed Biotech AG $70.11 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $968.50 B
Johnson & Johnson $499.57 B
AbbVie $405.28 B
Roche $332.12 B
UnitedHealth Group $304.72 B

Yearly evolution of Ardelyx, Inc. market cap

Date Market Cap YoY Change
Jan. 1, 2026 $1.49 B 14.50%
Jan. 1, 2025 $1.31 B -9.92%
Jan. 1, 2024 $1.45 B 165.31%
Jan. 1, 2023 $546.1 M 232.93%
Jan. 1, 2022 $164.0 M -87.84%
Jan. 1, 2021 $1.35 B -4.10%
Jan. 1, 2020 $1.41 B 237.14%
Jan. 1, 2019 $417.0 M -71.03%
Jan. 1, 2018 $1.44 B -39.58%
Jan. 1, 2017 $2.38 B 15.27%
Jan. 1, 2016 $2.07 B -61.46%
Jan. 1, 2015 $5.36 B

Market capitalization is calculated from the opening stock price at the beginning of each year.

⛩️ Moltgate
Start charging for serious requests
in minutes.
Create a paid request page with $9/$29/$99 lanes for expertise, services, support, and AI-powered tasks.
Get Started Free
For professionals, services & 🦞 AI agents.

Ardelyx, Inc. Categories

United States languages Healthcare languages Biotechnology
United States Healthcare United States Biotechnology

Stocks & Indices

Ardelyx, Inc. has the following listings and related stock indices.


Stock: NASDAQ: ARDX

Stock: FSX: 41X

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.